Pfizer will not cut sales force
Executive Summary
"The last thing we are going to do is pull back on our field force and our number of sales reps given the nature of our new product potential," Pfizer CFO David Shedlarz told the Merrill Lynch pharmaceutical and biotech conference Feb. 5 in New York City. Shedlarz noted that there has been speculation about the possibility of companies cutting back on sales reps in light of the increasing focus on compliance and relative lack of new product launches. [Editor's Note: More coverage of Shedlarz' discussion of the dynamics in marketing and sales will appear in 1"The Pink Sheet" DAILY Feb. 9. Visit our website, www.ThePinkSheetDAILY.com, to sign up for a free trial.]...